Results 161 to 170 of about 44,633 (211)

Genetic and Clinical Spectrum of Hereditary Transthyretin Amyloidosis in Brazil. [PDF]

J Peripher Nerv Syst
Maximiano-Alves G, Lavigne-Moreira C, Simões MV, Galvão AJP, Valicelli FH, Coneglian FS, Vegezzi E, Garibaldi PMM, Tomaselli PJ, Cortese A, Marques W.   +10 more
europepmc   +1 more source

Application of Omics Analysis in the Clinical Practice and Research of Transthyretin Amyloidosis. [PDF]

Genes (Basel)
Moriyama H, Shaikh FA, Yokota T.
europepmc   +1 more source

Dual pathology in aortic stenosis: Identifying transthyretin amyloidosis likelihood in patients referred for transcatheter aortic valve implantation. [PDF]

Int J Cardiol Heart Vasc
Schwarting SK, Alieva S, Chaudhry MU, Löw K, Grosu S, Massberg S, Deseive S, Steffen J.   +7 more
europepmc   +1 more source

Residual Graft Pathology During CABG as a Minimally Invasive Diagnostic Pathway for Transthyretin Amyloidosis. [PDF]

JACC Case Rep
Kuwahara A, Okada A, Yamaguchi K, Kutsuzawa R, Kawamoto N, Matsumoto M, Tateishi E, Fukushima S, Kitai T, Izumi C.   +9 more
europepmc   +1 more source

Sixty years of experience with hereditary transthyretin amyloidosis: Insights from the Swedish transthyretin amyloidosis registry. [PDF]

J Intern Med
Stenberg L, Pilebro B, Anan I, Baranda JM, Samuelsson K, Eldhagen P, Backlund R, Wixner J.   +7 more
europepmc   +1 more source

Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey. [PDF]

Cardio-Oncology, 2021
Background: Transthyretin amyloid cardiomyopathy results from the accumulation of wild-type (ATTRwt) or variant (ATTRv) transthyretin amyloid fibrils in the myocardium.
Mathew S Maurer, Angela Dispenzieri, Jonas Wixner   +2 more
exaly   +5 more sources

Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS) [PDF]

Cardiology and Therapy, 2022
INTRODUCTION: Wild-type transthyretin amyloidosis (ATTRwt amyloidosis) is a progressive disease resulting from the accumulation of wild-type transthyretin (TTR) amyloid fibrils, and is diagnosed primarily in males.
Mathew S Maurer, Arnt V Kristen, Angela Dispenzieri   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Emerging Therapies for Transthyretin Amyloidosis

Current Oncology Reports, 2023
This review provides an overview of the available therapies for treating neuropathic and/or cardiac manifestations of transthyretin amyloidosis (ATTR), as well as investigational therapeutic agents in ongoing clinical trials. We discuss additional emergent approaches towards thwarting this life-threatening disease that until recently was considered ...
Melissa R. Tsoi, Jeffrey H. Lin, Ayan R. Patel   +2 more
openaire   +2 more sources